NEHALI PATEL: Open Payments
NPI 1568969517 · GERMANTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$613 in 28 payments from 11 companies in 2025. Trend: 2023 $483 · 2024 $731 · 2025 $613
Food & beverage: $553Education: $60
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $109 |
| Novo Nordisk Inc | 5 | $98 |
| Lilly USA, LLC | 4 | $90 |
| Exact Sciences Corporation | 3 | $63 |
| Amgen Inc. | 3 | $60 |
| PFIZER INC. | 3 | $55 |
| GlaxoSmithKline, LLC. | 3 | $55 |
| Lundbeck LLC | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| Inspire Medical Systems, Inc. | 1 | $22 |
Products named: MOUNJARO, Cologuard Collection Kit, Ozempic, Veozah, TRELEGY ELLIPTA, PREVNAR 20, KRYSTEXXA, REXULTI.
Industry payments across MD — which companies pay providers there.
